Women's Isoflavone Soy Health (WISH) Trial
Phytoestrogens and Progression of Atherosclerosis
Sponsor: National Center for Complementary and Integrative Health (NCCIH)
A PHASE2 clinical study on Atherosclerosis, this trial is completed. The trial is conducted by National Center for Complementary and Integrative Health (NCCIH) and has accumulated 7 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jun 2023 — Jul 2024 [monthly]
Completed PHASE2
Phase: PHASE2_PHASE3 → PHASE2
-
Jan 2021 — Jun 2023 [monthly]
Completed PHASE2_PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
▶ Show 2 earlier versions
-
Apr 2017 — Jun 2018 [monthly]
Completed PHASE2_PHASE3
Status: Unknown Status → Completed
-
Jan 2017 — Apr 2017 [monthly]
Unknown Status PHASE2_PHASE3
First recorded
Apr 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Center for Complementary and Integrative Health (NCCIH)
- Office of Dietary Supplements (ODS)
- Office of Research on Women's Health (ORWH)
- Solae, LLC
- University of Southern California
For direct contact, visit the study record on ClinicalTrials.gov .